KOD
Kodiak Sciences Inc.
Biotechnology · Healthcare · United States
99.18
close · 2026-10-30
value
92
cheaper than peers92
quality
9
stronger fundamentals9
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 1 year ago | -1.9% | 92 |
| cash flow yield, latest year | -2.2% | 92 |
| earnings yield, 1 year ago | -3.4% | 92 |
| earnings yield, 2 years ago | -5.0% | 88 |
| earnings yield, latest year | -4.4% | 88 |
| earnings yield, 3 years ago | -6.4% | 81 |
| cash flow yield, 2 years ago | -3.1% | 81 |
| cash flow yield, 3 years ago | -4.1% | 70 |
| price to book | 101.83× | 0 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| debt to equity | 49.9% | 15 |
| return on equity | -208.8% | 12 |
3 of 4 measures available
Facts
| market cap | $6B |
| free cash flow | -$52.2M |
| employees | 130 |
| first trade | 2018-10-04 |
| next earnings | not reported |
| fundamentals updated | 2026-07-29 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -4.32 | -3.35 | -4.97 | -6.39 |
| free cash flow | -$136.5M | -$117.7M | -$195.6M | -$253.8M |
| net income | -$230.0M | -$176.2M | -$260.5M | -$333.8M |
| revenue | $0 | $0 | $0 | $0 |